Effect of p53 haploinsufficiency on melphalan-induced genotoxic effects in mouse bone marrow and peripheral blood

Mice heterozygous for a p53 null mutation develop tumours induced by genotoxic carcinogens with a shorter latency than wild type mice and have been proposed as an alternate animal model for carcinogenicity testing. Some literature data suggest that p53+/− mice might also be more sensitive to the sho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 2007-02, Vol.615 (1), p.57-65
Hauptverfasser: Ranaldi, R., Palma, S., Tanzarella, C., Lascialfari, A., Cinelli, S., Pacchierotti, F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 65
container_issue 1
container_start_page 57
container_title Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis
container_volume 615
creator Ranaldi, R.
Palma, S.
Tanzarella, C.
Lascialfari, A.
Cinelli, S.
Pacchierotti, F.
description Mice heterozygous for a p53 null mutation develop tumours induced by genotoxic carcinogens with a shorter latency than wild type mice and have been proposed as an alternate animal model for carcinogenicity testing. Some literature data suggest that p53+/− mice might also be more sensitive to the short-term effects of genotoxic agents and manifest a haploinsufficiency phenotype that could contribute to the higher tumour susceptibility. We have compared the induction of micronuclei in bone marrow and blood of p53+/− and p53+/+ isogenic mice after treatment with a single or multiple doses of melphalan (MLP), a crosslinking genotoxic carcinogen. We have also characterized the mechanism of micronucleus induction with CREST staining of kinetochore proteins to distinguish between chromosome break- and chromosome loss-induced micronuclei. Significant increases of micronucleated bone marrow polychromatic erythrocytes and blood reticulocytes were induced under all MLP exposure conditions. The frequency of micronucleated blood erythrocytes increased linearly with duration of exposure. Micronuclei were essentially a consequence of chromosome break events. After a single MLP dose, a significant reduction of the frequency of polychromatic erythrocytes in bone marrow of p53+/+ animals suggested the induction of cytotoxicity/cell cycle delay. This effect was not observed in p53+/− mice. We believe this finding to provide some evidence of a haploinsufficiency phenotype in the modulation of cell cycle/apoptotic pathways mediated by the p53 protein. In bone marrow of wild type mice, an increased effect of multiple MLP doses was detected over that of a single administration, whereas, in p53+/− mice, no differential effect was found of different exposure durations. Possibly, the probability of micronucleus formation increased under chronic exposure because of increased cell division in response to peripheral anemia and a reduction of p53 protein level had a small effect on cell cycle modulation and on such indirect mechanism of micronucleus induction. However, pairwise comparisons between the frequencies of cells with micronuclei in wild type and p53+/− mice under all exposure conditions did not show statistically significant differences, suggesting that the observed effects of p53 haploinsufficiency were weak and temporary and a higher/faster induction of irreversible chromosome damage could not account for the increased susceptibility of p53+/− mice to MLP-induced tumours.
doi_str_mv 10.1016/j.mrfmmm.2006.10.001
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20289655</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0027510706002909</els_id><sourcerecordid>20289655</sourcerecordid><originalsourceid>FETCH-LOGICAL-c488t-8842f533ae52a87d853fb90afc007e7f29382e3fe970ca98e2443ace9954c39c3</originalsourceid><addsrcrecordid>eNqFkUtr3DAUhUVpaCaPf1CKVt15ciVZtrQphJC0gUA2KXQnNPJVR4NtOdK4Sf59NJmB7JrVhct37uMcQr4yWDJgzcVmOSQ_DMOSAzSltQRgn8iCqVZUTMg_n8kCgLeVZNAek5OcNwBQ60Z_IcesZaCVVgvyeO09ui2Nnk5S0LWd-hjGPHsfXMDRvdA40gH7aW17O1Zh7GaHHf2LY9zG5-AovukzDQWLc0a6iiPSwaYUn6gdOzphCtMak-3pqo-xOyNH3vYZzw_1lPy-uX64-lXd3f-8vbq8q1yt1LZSquZeCmFRcqvaTknhVxqsdwAttp5roTgKj7oFZ7VCXtfCOtRa1k5oJ07J9_3cKcXHGfPWDCE77MsbWA41HLjSjZQfgkw3AELwAtZ70KWYc0JvphTKpy-GgdllYjZmn4nZZbLrlkyK7Nth_rwasHsXHUIowI89gMWOfwGTyW_eYxdS8dZ0Mfx_wyt7sqCi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19600332</pqid></control><display><type>article</type><title>Effect of p53 haploinsufficiency on melphalan-induced genotoxic effects in mouse bone marrow and peripheral blood</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Ranaldi, R. ; Palma, S. ; Tanzarella, C. ; Lascialfari, A. ; Cinelli, S. ; Pacchierotti, F.</creator><creatorcontrib>Ranaldi, R. ; Palma, S. ; Tanzarella, C. ; Lascialfari, A. ; Cinelli, S. ; Pacchierotti, F.</creatorcontrib><description>Mice heterozygous for a p53 null mutation develop tumours induced by genotoxic carcinogens with a shorter latency than wild type mice and have been proposed as an alternate animal model for carcinogenicity testing. Some literature data suggest that p53+/− mice might also be more sensitive to the short-term effects of genotoxic agents and manifest a haploinsufficiency phenotype that could contribute to the higher tumour susceptibility. We have compared the induction of micronuclei in bone marrow and blood of p53+/− and p53+/+ isogenic mice after treatment with a single or multiple doses of melphalan (MLP), a crosslinking genotoxic carcinogen. We have also characterized the mechanism of micronucleus induction with CREST staining of kinetochore proteins to distinguish between chromosome break- and chromosome loss-induced micronuclei. Significant increases of micronucleated bone marrow polychromatic erythrocytes and blood reticulocytes were induced under all MLP exposure conditions. The frequency of micronucleated blood erythrocytes increased linearly with duration of exposure. Micronuclei were essentially a consequence of chromosome break events. After a single MLP dose, a significant reduction of the frequency of polychromatic erythrocytes in bone marrow of p53+/+ animals suggested the induction of cytotoxicity/cell cycle delay. This effect was not observed in p53+/− mice. We believe this finding to provide some evidence of a haploinsufficiency phenotype in the modulation of cell cycle/apoptotic pathways mediated by the p53 protein. In bone marrow of wild type mice, an increased effect of multiple MLP doses was detected over that of a single administration, whereas, in p53+/− mice, no differential effect was found of different exposure durations. Possibly, the probability of micronucleus formation increased under chronic exposure because of increased cell division in response to peripheral anemia and a reduction of p53 protein level had a small effect on cell cycle modulation and on such indirect mechanism of micronucleus induction. However, pairwise comparisons between the frequencies of cells with micronuclei in wild type and p53+/− mice under all exposure conditions did not show statistically significant differences, suggesting that the observed effects of p53 haploinsufficiency were weak and temporary and a higher/faster induction of irreversible chromosome damage could not account for the increased susceptibility of p53+/− mice to MLP-induced tumours.</description><identifier>ISSN: 0027-5107</identifier><identifier>ISSN: 1386-1964</identifier><identifier>EISSN: 1873-135X</identifier><identifier>EISSN: 0027-5107</identifier><identifier>DOI: 10.1016/j.mrfmmm.2006.10.001</identifier><identifier>PMID: 17109898</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Blood Cells - drug effects ; Bone Marrow Cells - drug effects ; Erythrocytes - drug effects ; Gene Deletion ; Genes, p53 ; Heterozygote ; Male ; Melphalan ; Melphalan - administration &amp; dosage ; Melphalan - toxicity ; Mice ; Mice, Inbred C57BL ; Mice, Mutant Strains ; Micronuclei ; Micronucleus Tests ; Mouse bone marrow ; Mutagens - administration &amp; dosage ; Mutagens - toxicity ; p53 ; Reticulocytes - drug effects</subject><ispartof>Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 2007-02, Vol.615 (1), p.57-65</ispartof><rights>2006 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c488t-8842f533ae52a87d853fb90afc007e7f29382e3fe970ca98e2443ace9954c39c3</citedby><cites>FETCH-LOGICAL-c488t-8842f533ae52a87d853fb90afc007e7f29382e3fe970ca98e2443ace9954c39c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17109898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ranaldi, R.</creatorcontrib><creatorcontrib>Palma, S.</creatorcontrib><creatorcontrib>Tanzarella, C.</creatorcontrib><creatorcontrib>Lascialfari, A.</creatorcontrib><creatorcontrib>Cinelli, S.</creatorcontrib><creatorcontrib>Pacchierotti, F.</creatorcontrib><title>Effect of p53 haploinsufficiency on melphalan-induced genotoxic effects in mouse bone marrow and peripheral blood</title><title>Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis</title><addtitle>Mutat Res</addtitle><description>Mice heterozygous for a p53 null mutation develop tumours induced by genotoxic carcinogens with a shorter latency than wild type mice and have been proposed as an alternate animal model for carcinogenicity testing. Some literature data suggest that p53+/− mice might also be more sensitive to the short-term effects of genotoxic agents and manifest a haploinsufficiency phenotype that could contribute to the higher tumour susceptibility. We have compared the induction of micronuclei in bone marrow and blood of p53+/− and p53+/+ isogenic mice after treatment with a single or multiple doses of melphalan (MLP), a crosslinking genotoxic carcinogen. We have also characterized the mechanism of micronucleus induction with CREST staining of kinetochore proteins to distinguish between chromosome break- and chromosome loss-induced micronuclei. Significant increases of micronucleated bone marrow polychromatic erythrocytes and blood reticulocytes were induced under all MLP exposure conditions. The frequency of micronucleated blood erythrocytes increased linearly with duration of exposure. Micronuclei were essentially a consequence of chromosome break events. After a single MLP dose, a significant reduction of the frequency of polychromatic erythrocytes in bone marrow of p53+/+ animals suggested the induction of cytotoxicity/cell cycle delay. This effect was not observed in p53+/− mice. We believe this finding to provide some evidence of a haploinsufficiency phenotype in the modulation of cell cycle/apoptotic pathways mediated by the p53 protein. In bone marrow of wild type mice, an increased effect of multiple MLP doses was detected over that of a single administration, whereas, in p53+/− mice, no differential effect was found of different exposure durations. Possibly, the probability of micronucleus formation increased under chronic exposure because of increased cell division in response to peripheral anemia and a reduction of p53 protein level had a small effect on cell cycle modulation and on such indirect mechanism of micronucleus induction. However, pairwise comparisons between the frequencies of cells with micronuclei in wild type and p53+/− mice under all exposure conditions did not show statistically significant differences, suggesting that the observed effects of p53 haploinsufficiency were weak and temporary and a higher/faster induction of irreversible chromosome damage could not account for the increased susceptibility of p53+/− mice to MLP-induced tumours.</description><subject>Animals</subject><subject>Blood Cells - drug effects</subject><subject>Bone Marrow Cells - drug effects</subject><subject>Erythrocytes - drug effects</subject><subject>Gene Deletion</subject><subject>Genes, p53</subject><subject>Heterozygote</subject><subject>Male</subject><subject>Melphalan</subject><subject>Melphalan - administration &amp; dosage</subject><subject>Melphalan - toxicity</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Mutant Strains</subject><subject>Micronuclei</subject><subject>Micronucleus Tests</subject><subject>Mouse bone marrow</subject><subject>Mutagens - administration &amp; dosage</subject><subject>Mutagens - toxicity</subject><subject>p53</subject><subject>Reticulocytes - drug effects</subject><issn>0027-5107</issn><issn>1386-1964</issn><issn>1873-135X</issn><issn>0027-5107</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtr3DAUhUVpaCaPf1CKVt15ciVZtrQphJC0gUA2KXQnNPJVR4NtOdK4Sf59NJmB7JrVhct37uMcQr4yWDJgzcVmOSQ_DMOSAzSltQRgn8iCqVZUTMg_n8kCgLeVZNAek5OcNwBQ60Z_IcesZaCVVgvyeO09ui2Nnk5S0LWd-hjGPHsfXMDRvdA40gH7aW17O1Zh7GaHHf2LY9zG5-AovukzDQWLc0a6iiPSwaYUn6gdOzphCtMak-3pqo-xOyNH3vYZzw_1lPy-uX64-lXd3f-8vbq8q1yt1LZSquZeCmFRcqvaTknhVxqsdwAttp5roTgKj7oFZ7VCXtfCOtRa1k5oJ07J9_3cKcXHGfPWDCE77MsbWA41HLjSjZQfgkw3AELwAtZ70KWYc0JvphTKpy-GgdllYjZmn4nZZbLrlkyK7Nth_rwasHsXHUIowI89gMWOfwGTyW_eYxdS8dZ0Mfx_wyt7sqCi</recordid><startdate>20070203</startdate><enddate>20070203</enddate><creator>Ranaldi, R.</creator><creator>Palma, S.</creator><creator>Tanzarella, C.</creator><creator>Lascialfari, A.</creator><creator>Cinelli, S.</creator><creator>Pacchierotti, F.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20070203</creationdate><title>Effect of p53 haploinsufficiency on melphalan-induced genotoxic effects in mouse bone marrow and peripheral blood</title><author>Ranaldi, R. ; Palma, S. ; Tanzarella, C. ; Lascialfari, A. ; Cinelli, S. ; Pacchierotti, F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c488t-8842f533ae52a87d853fb90afc007e7f29382e3fe970ca98e2443ace9954c39c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Blood Cells - drug effects</topic><topic>Bone Marrow Cells - drug effects</topic><topic>Erythrocytes - drug effects</topic><topic>Gene Deletion</topic><topic>Genes, p53</topic><topic>Heterozygote</topic><topic>Male</topic><topic>Melphalan</topic><topic>Melphalan - administration &amp; dosage</topic><topic>Melphalan - toxicity</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Mutant Strains</topic><topic>Micronuclei</topic><topic>Micronucleus Tests</topic><topic>Mouse bone marrow</topic><topic>Mutagens - administration &amp; dosage</topic><topic>Mutagens - toxicity</topic><topic>p53</topic><topic>Reticulocytes - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ranaldi, R.</creatorcontrib><creatorcontrib>Palma, S.</creatorcontrib><creatorcontrib>Tanzarella, C.</creatorcontrib><creatorcontrib>Lascialfari, A.</creatorcontrib><creatorcontrib>Cinelli, S.</creatorcontrib><creatorcontrib>Pacchierotti, F.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ranaldi, R.</au><au>Palma, S.</au><au>Tanzarella, C.</au><au>Lascialfari, A.</au><au>Cinelli, S.</au><au>Pacchierotti, F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of p53 haploinsufficiency on melphalan-induced genotoxic effects in mouse bone marrow and peripheral blood</atitle><jtitle>Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis</jtitle><addtitle>Mutat Res</addtitle><date>2007-02-03</date><risdate>2007</risdate><volume>615</volume><issue>1</issue><spage>57</spage><epage>65</epage><pages>57-65</pages><issn>0027-5107</issn><issn>1386-1964</issn><eissn>1873-135X</eissn><eissn>0027-5107</eissn><abstract>Mice heterozygous for a p53 null mutation develop tumours induced by genotoxic carcinogens with a shorter latency than wild type mice and have been proposed as an alternate animal model for carcinogenicity testing. Some literature data suggest that p53+/− mice might also be more sensitive to the short-term effects of genotoxic agents and manifest a haploinsufficiency phenotype that could contribute to the higher tumour susceptibility. We have compared the induction of micronuclei in bone marrow and blood of p53+/− and p53+/+ isogenic mice after treatment with a single or multiple doses of melphalan (MLP), a crosslinking genotoxic carcinogen. We have also characterized the mechanism of micronucleus induction with CREST staining of kinetochore proteins to distinguish between chromosome break- and chromosome loss-induced micronuclei. Significant increases of micronucleated bone marrow polychromatic erythrocytes and blood reticulocytes were induced under all MLP exposure conditions. The frequency of micronucleated blood erythrocytes increased linearly with duration of exposure. Micronuclei were essentially a consequence of chromosome break events. After a single MLP dose, a significant reduction of the frequency of polychromatic erythrocytes in bone marrow of p53+/+ animals suggested the induction of cytotoxicity/cell cycle delay. This effect was not observed in p53+/− mice. We believe this finding to provide some evidence of a haploinsufficiency phenotype in the modulation of cell cycle/apoptotic pathways mediated by the p53 protein. In bone marrow of wild type mice, an increased effect of multiple MLP doses was detected over that of a single administration, whereas, in p53+/− mice, no differential effect was found of different exposure durations. Possibly, the probability of micronucleus formation increased under chronic exposure because of increased cell division in response to peripheral anemia and a reduction of p53 protein level had a small effect on cell cycle modulation and on such indirect mechanism of micronucleus induction. However, pairwise comparisons between the frequencies of cells with micronuclei in wild type and p53+/− mice under all exposure conditions did not show statistically significant differences, suggesting that the observed effects of p53 haploinsufficiency were weak and temporary and a higher/faster induction of irreversible chromosome damage could not account for the increased susceptibility of p53+/− mice to MLP-induced tumours.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>17109898</pmid><doi>10.1016/j.mrfmmm.2006.10.001</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0027-5107
ispartof Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis, 2007-02, Vol.615 (1), p.57-65
issn 0027-5107
1386-1964
1873-135X
0027-5107
language eng
recordid cdi_proquest_miscellaneous_20289655
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Blood Cells - drug effects
Bone Marrow Cells - drug effects
Erythrocytes - drug effects
Gene Deletion
Genes, p53
Heterozygote
Male
Melphalan
Melphalan - administration & dosage
Melphalan - toxicity
Mice
Mice, Inbred C57BL
Mice, Mutant Strains
Micronuclei
Micronucleus Tests
Mouse bone marrow
Mutagens - administration & dosage
Mutagens - toxicity
p53
Reticulocytes - drug effects
title Effect of p53 haploinsufficiency on melphalan-induced genotoxic effects in mouse bone marrow and peripheral blood
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T18%3A56%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20p53%20haploinsufficiency%20on%20melphalan-induced%20genotoxic%20effects%20in%20mouse%20bone%20marrow%20and%20peripheral%20blood&rft.jtitle=Mutation%20Research-Fundamental%20and%20Molecular%20Mechanisms%20of%20Mutagenesis&rft.au=Ranaldi,%20R.&rft.date=2007-02-03&rft.volume=615&rft.issue=1&rft.spage=57&rft.epage=65&rft.pages=57-65&rft.issn=0027-5107&rft.eissn=1873-135X&rft_id=info:doi/10.1016/j.mrfmmm.2006.10.001&rft_dat=%3Cproquest_cross%3E20289655%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19600332&rft_id=info:pmid/17109898&rft_els_id=S0027510706002909&rfr_iscdi=true